All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 201 of 206 pages ‹ First < 199 200 201 202 203 > Last ›
HSL2873
 Hargraves R.
 Introduction
 Journal of Drug Issues 1976;6:1-5
 
HSL2878
 Lexchin J.
 About those drug ads . . . 
 Canadian Family Physician 1976;22:109-110
 
HSL2879
 McCaffery M.
 About those drug ads . . .
 Canadian Family Physician 1976;22:110
 
HSL2880
 Morgan AH, Jeffers TA, Petrie JC, Walker W.
 Drug advertising in medical journals
 British Journal of Clinical Pharmacology 1976;3:1057-1060
 
HSL2881
 Mosher EH.
 Portrayal of women in drug advertising:  a medical betrayal
 Journal of Drug Issues 1976;6:72-78
 
HSL2882
 Nelson G.
 Advertising and the national health
 Journal of Drug Issues 1976;6:28-33
 
HSL2883
 Petersen B, Kuriansky JB, Konheim CS, Anderson RS, Tesar J, Podell RN, Ho A, Cowan NM.
 Television advertising and drug use
 American Journal of Public Health 1976;66:(10):975-978
 
HSL2884
 Schwartzman D.
 Promotional expenditures
 The Johns Hopkins University Press 1976;182-211
 
HSL2885
 Silverman M, Lee PR.
 Pills, profits & politics
 University of California Press 1976;
 
HSL2886
 Singer R.
 Ads and readers
 Canadian Family Physician 1976;22:635
 
HSL2887
 Smith MC.
 Portrayal of the elderly in prescription drug advertising
 The Gerontologist 1976;16:329-334
 
HSL2888
 Spiller GW.
 Ads and readers
 Canadian Family Physician 1976;22:635
 
HSL2889
 Stimson GV.
 The extent of advertising of pharmaceutical products.
 J R Coll Gen Pract 1976;26:
 
HSL2890
 Stimson GV.
 The use of references in drug advertisements.
 J R Coll Gen Pract 1976;26:
 
HSL2900
 Brooke P.
 Promotional parameters: a preliminary examination of promotional expenditures
 Journal of Drug Issues 1976;6:(1):21-27
 
HSL2901
 Choate R, Debevoise N.
 Caution! Keep this commercial out of reach of children!
 Journal of Drug Issues 1976;6:(1):91-98
 
HSL2902
 Cope JD.
 Television advertising of nonprescription medicines: The case for the defendant
 Journal of Drug Issues 1976;6:(1):85-90
 
HSL2903
 Donegan TJ.
 The role of the Federal Trade Commission in regulating drug advertising: 1975 perspective
 Journal of Drug Issues 1976;6:(1):99-104
 
HSL2904
 Halberstam M.
 The other side of the coin: another physician views drug advertising
 Journal of Drug Issues 1976;6:(1):9-12
 
HSL2905
 Jensen GF, Christiansen RL.
 Drug advertising should be banned: Utah's approach
 Journal of Drug Issues 1976;6:(1):65-71
 
HSL2906
 Kuriansky JB.
 TV advertising and abuse of over-the-counter drugs
 Journal of Drug Issues 1976;6:(1):79-84
 
HSL2907
 Nellis M.
 Ineffectiveness x Delay = Danger: a public health equation for failure
 Journal of Drug Issues 1976;6:(1):56-59
 
HSL2908
 Pekkanen J.
 The impact of promotion on physicians' prescribing patterns
 Journal of Drug Issues 1976;6:(1):13-20
 
HSL2909
 Reinstein P.
 A regulator's perception of drug advertising
 Journal of Drug Issues 1976;6:(1):60-64
 
HSL2910
 Rucker TR.
 Drug information for practitioners: commercial obligation or social responsibility?
 Journal of Drug Issues 1976;6:(1):43-49
 
HSL2911
 Ruskin A.
 Social and regulatory consequences of misleading medical information
 Journal of Drug Issues 1976;6:(1):50-55
 
HSL2912
 Stetler CJ.
 Advertising of prescription medicines.
 Journal of Drug Issues 1976;6:(1):34-42
 
HSL2913
 Watson M.
 A physician views drug advertising
 Journal of Drug Issues 1976;6:(1):
 
HSL8574
 Stahel AI.
 Time for decision 
 Australian Journal of Hospital Pharmacy 1976;6:(1):20-21
 
HSL9087
 Silverman MM
 The Drugging of the Americas: How Multinational Drug Companies Say One Thing About Their Products to Physicians in the United States and Another Thing to Physicians in Latin America
 Berkeley: University Of California Press 1976
 
http://www.amazon.com/Drugging-Americas-Multinational-Companies-Physicians/dp/0520031229/ref=sr_1_1/102-1249992-1219339?ie=UTF8&s=books&qid=1175307707&sr=1-1
HSL8843
 Mixson P.
 Britain's nationalized pharmacy: lesson for the U.S. 
 Drug Topics 1975 Dec 1;119:21, 26-27
 
HSL8571
 What you should know about the FTC 
 J Am Pharm Assoc. 1975 Dec;15:(12):668-77
 
HSL8842
 Smiler BA.
 Drugs in dentistry 
 Medical Marketing and Media 1975 Dec;10:13-16
 
HSL2857
 Stimson GV.
 Information contained in drug advertisements.
 BMJ. 1975 Nov 29;4:(5995):508-9
 
HSL2856
 Jacoby J, Small C.
 The FDA approach to defining misleading advertising
 Journal of Marketing 1975 Oct;39:65-73
 
HSL8573
 Whitney HA Jr.
 Educating the public about drugs.
 
Drug Intell Clin Pharm 1975 Oct;9:(10):571
 
HSL8846
 Kleinfeld VA.
 Overview of some recent developments in the drug field 
 Food Drug Cosmet Law J 1975 Aug;30:458-468
 
HSL8844
 Stetler CJ.
 Are drug prices an profits without honor? 
 Medical Marketing and Media 1975 Jul;10:11-12, 14, 16
 
HSL8849
 Kushner D.
 FTC's rules: get set for long controversy 
 American Druggist 1975 Jul;172:18, 37-44, 47
 
HSL8847
 Mant A.
 Determinants of prescribing of psychoactive drugs by general practitioners.
 
Med J Aust 1975 Jun 14;1:(24):743-9
 
HSL2062
 Stimson GV.
 The message of psychotropic drug ads.
 J Commun 1975 Summer;25:(3):153-60
 
HSL2843
 Harelik JH, Johnston PM, Rivers NP, Ryan MR.
 Pharmacist and physician evaluation of drug information sources.
 Am J Hosp Pharm 1975 Jun;32:(6):594-7
 
HSL2842
 Bell W
 The Compendium of Pharmaceuticals and Specialties
 1975 May 30-31;
 
HSL2846
 Mailloud J.
 The drug companies role in the supply of information
 1975 May 30-31;
 
HSL2855
 Stimson G.
 Women in a doctored world
 New Society 1975 May 1;32:265-267
 
HSL2852
 Williamson PM.
 How general practitioners assess risks in using new drugs.
 J R Coll Gen Pract 1975 May;25:(154):383-6
 
HSL8845
 Ellenhorn MJ.
 Future shock: drug therapy and the US pharmaceutical industry 
 Journal of Clinical Pharmacology 1975 May-Jun;15:385-400
 
http://jcp.sagepub.com/cgi/reprint/15/5/385
HSL8851
 Barrows J.
 Prescription drug labeling for patients 
 Food Drug Cosmet Law J 1975 Feb;30:98-104
 
HSL8855
 Hemminki E.
 Review of literature on the factors affecting drug prescribing.
 
Soc Sci Med 1975 Feb;9:(2):111-6
 
HSL2849
 Prather J, Fidell LS.
 Sex differences in the content and style of medical advertisements.
 Soc Sci Med 1975 Jan;9:(1):23-6
 
HSL2850
 Smith GH, Sorby DL, Sharp LJ.
 Physician attitudes toward drug information resources.
 Am J Hosp Pharm 1975 Jan;32:(1):19-25
 
HSL8839
 Higgins DG.
 Aspects of medical communications in the United Kingdom.
 
Drug Inf J 1975 Jan-Apr;9:(1):32-7
 
HSL2841
 Prescription drug ads now to be prescreened
 Canadian Family Physician 1975;21:(8):23
 
HSL2844
 Huse KD.
 Medical advertising—the other side of the coin
 Patient Management 1975;4:(6):36-37
 
HSL2845
 Kales A, Kales JD.
 Shortcomings in the evaluation and promotion of hypnotic drugs
 New England Journal of Medicine 1975;293:826-827
 
HSL2847
 Mant A, Darroch DB.
 Media images and medical images
 Social Science and Medicine 1975;9:613-618
 
HSL2848
 McCaffery M.
 The muzzle muddle
 Canadian Family Physician 1975;21:(11):7
 
HSL2851
 Telser L, Best W, Egan JW, Higinbotham HN.
 The theory of supply with applications to the ethical pharmaceutical industry
 Journal of Law and Economics 1975;18:449-478
 
HSL2853
 Responsible advertising
 Medical Journal of Australia 1975;62:90
 
HSL2854
 Erill S, Souich PD, Garcia-Sevilla JA.
 Chloramphenicol-containing drugs.  A report from Spain
 J Clin Pharmacol . 1975;15:401-404
 
http://jcp.sagepub.com/cgi/reprint/15/5/401
HSL8576
 Rucker TD.
 Role of the pharmaceutical industry in a dynamic health care system 
 Drugs Health Care 1975;2:(2):86-95
 
HSL8577
 Lee AM.
 Interdependence of prescription drugs and other health care costs 
 Drugs Healt -Care 1975;2:(2):75-85
 
HSL8578
 Hornbrook MC.
 Commentary on the interdependence of prescription drugs and other health care costs: some implications for research 
 Drugs Health Care 1975;2:(4):255-265
 
HSL8850
 Pharmacy board not authorized to prohibit drug price advertising 
 Citation 1975;30:(6):
 
HSL8856
 Manufacturer liable for erroneous drug addiction claims 
 Citation 1975;30:(7):107-108
 
HSL9052
 Illich I.
 Medical Nemesis
 : Calder & Boyar 1975
 
http://www.amazon.com/Medical-Nemesis-Ivan-Illich/dp/0394712455
HSL9059
 Klass A.
 There's Gold in Them Thar Pills: An Enquiry into the Medical-Industrial Complex 
 : Penguin 1975
 
http://www.amazon.com/Theres-Gold-Them-Pills-Medical-Industrial/dp/0140523146/ref=sr_1_1/102-1249992-1219339?ie=UTF8&s=books&qid=1175165931&sr=1-1
HSL12234
 Levine JM, Valle RS.
 The convert as a credible communicator
 Social Behavior and Personality 1975;3:81-90
 
HSL2825
 Woods D.
 Prescription drugs and the patient's health.
 Can Med Assoc J 1974 Dec 7;111:(11):1269
 
HSL8858
 Steiner KC, Garner DD.
 Price as a component of prescription drug advertising 
 Medical Marketing and Media 1974 Dec;9:15-20
 
HSL2840
 Dryden A.
 PMAC setting up board to pre-clear ads
 Maclean Hunter 1974 Nov 18;79:3
 
HSL2817
 Mcree C, Corder BF, Haizlip T.
 Psychiatrists' responses to sexual bias in pharmaceutical advertising.
 Am J Psychiatry 1974 Nov;131:(11):1273-5
 
HSL8569
 Response of the American Pharmaceutical Association to the June 14, 1974, inquiry of the Federal Trade Commission.
 J Am Pharm Assoc 1974 Oct;14:(10):538-42,
 
HSL2819
 Moser RH.
 Editorial: The continuing search: FDA drug information survey.
 JAMA 1974 Sep 2;229:(10):1336-8
 
HSL2810
 Erill S.
 Clinical pharmacology in Spain.
 Clin Pharmacol Ther 1974 Sep;16:(3):597-604
 
HSL2839
 Editorial
 Advertising standards and the National Medical Media Council.
 Med J Aust. 1974 Aug 10;2:(6):189-90
 
HSL2838
 Siegelman S.
 How pharmacists rate detailmen
 American Druggist 1974 Aug 1;170:(3):19, 56-62
 
HSL2821
 Schreier HA, Berger L.
 Letter: On medical imperialism.
 Lancet 1974 Jun 8;1:(7867):1161
 
HSL8862
 Walters PG.
 FDA's program to improve consumers' and health professionals' ability to select medically effective drugs 
 Hosp Formul Manage 1974 Jun;9:17-20, 50
 
HSL2826
 Gould D.
 Can we handle modern drugs?
 New Scientist 1974 May 23;62:(899):460-1
 
HSL2827
 Greenberg D.
 Cleaning up the drug trade
 New Scientist 1974 May 23;62:491
 
HSL8869
 Inquisitive Federal Trade Commission (FTC) starts poking into pharmacy field 
 American Druggist 1974 May 1;169:74-75
 
HSL8854
 Schamberg IL.
 The quality and cost of prescription drugs.
 
J Am Pharm Assoc 1974 May;14:(5):241-3
 
HSL8861
 Pendergast WR.
 FDA regulations-a ten-year assessment 
 Medical Marketing and Media 1974 May;9:20, 22, 26-27
 
HSL2813
 Hemminki E.
 The effect of a doctor's personal characteristics and working circumstances on the prescribing of psychotropic drugs.
 Med Care 1974 Apr;12:(4):351-7
 
HSL8870
 Decristoforo R, Fortner CL.
 Review of potential drug interactions between OTC (over-the-counter) and prescription drugs 
 Hosp Formul Manage 1974 Apr;10:20-31, 41
 
HSL8866
 Davis S.
 Update on computerized media evaluation 
 Medical Marketing and Media 1974 Mar;9:13-15
 
HSL8874
 Display the prescription price poster, but not too conspicuously 
 Am Drug Merch 1974 Feb 1;169:32-36, 46
 
HSL8859
 Miller R.
 Prescribing habits of physicians. Parts 7-8. Sources of information on drugs and their influence on prescribing and a theoretical model for the adoption of drug innovations 
 Drug Intell Clin Pharm 1974 Feb;8:81-91
 
HSL8863
 Hoare RG.
 Pharmaceutical company 
 Postgrad Med J 1974 Feb;50:85-87
 
HSL2806
 Denies ads mislead, manipulate
 Drug Merchandising 1974;55:(4):51
 
HSL2807
 Findings and conclusions of the NCCC [National Council of Churches of Christ] project on drug advertising
 Journal of Drug Issues 1974;4:310-312
 
HSL2808
 Bowes R.
 The industry as pusher
 Journal of Drug Issues 1974;4:238-242
 
HSL2809
 Cooperstock R.
 Some factors involved in the increased prescribing of psychotropic drugs
 Alcoholism and Drug Addiction Research Foundation of Ontario 1974;
 
HSL2811
 Greenfield P, Wolff F.
 The pressures of drug advertising on physicians and patients
 Journal of Drug Issues 1974;4:254-259
 
HSL2812
 Hay DR.
 Postal pollution
 New Zealand Medical Journal 1974;80:464
 
HSL2814
 Hess SW.
 Communicating with physicians
 Journal of Advertising Research 1974;14:(1):13-18
 
HSL2815
 Kallir J.
 An advertiser’s view of drug advertising
 Journal of Drug Issues 1974;4:283-286
 
HSL2816
 Knight JL, Baumgartner RP.
 Quality control information—its availability from pharmaceutical manufacturers
 Hospital Formulary Management 1974;9:(9):35, 37, 40-42, 50
 
HSL2818
 Miller RR.
 Prescribing habits of physicians:  a review of studies on prescribing of drugs.  Parts VII-Viii
 Drug Intelligence and Clinical Pharmacy 1974;8:81-91
 
Page 201 of 206 pages ‹ First < 199 200 201 202 203 > Last ›
 








 


